黑色素改善了模拟微重力诱导的线粒体功能障碍和肝细胞中的脂质代谢失调
Yue Xiong1, Chiyuan Ma1, Qin Li1
1Center for Energy Metabolism and Reproduction, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
概括
模拟的微重力会损害肝细胞,导致细胞死亡和代谢问题. 黑素是一种强大的抗氧化剂,可以逆转这些不良影响,为肝脏健康提供潜在的治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 空间生物学 空间生物学
- 代谢综合征是代谢综合征的一种.
背景情况:
- 肝脏是参与许多代谢过程的重要器官.
- 微重力暴露对肝功能构成风险,并可能导致代谢障碍.
- 了解微重力对肝细胞影响的分子机制对于开发对策至关重要.
研究的目的:
- 为了研究模拟微重力 (SMG) 对肝细胞的不良影响.
- 探索SMG诱导的肝细胞损伤背后的分子机制.
- 评估黑激素在减轻这些不良影响方面的潜在治疗作用.
主要方法:
- 使用随机定位机培养肝细胞以模拟微重力.
- 评估了细胞活力,细胞循环,细胞亡,脂质积累,甘油三 (TG) 和活性氧物种 (ROS) 水平.
- 评估了线粒体功能.
- 进行RNA测序以分析基因表达变化,特别是脂质代谢途径.
主要成果:
- SMG显著降低了肝细胞活力,诱导细胞循环停止,并促进了细胞亡.
- 微重力模拟导致脂质积累增加,TG和ROS水平升高,线粒体功能受损.
- 在SMG条件下,RNA测序揭示了参与脂质代谢的基因的上调,如PPARγ,PLIN2,CD36和FABP.
- 黑色素治疗有效地抑制了观察到的缺陷,包括亡,脂质积累和ROS产生.
结论:
- 模拟的微重力通过涉及细胞循环停止,细胞亡,脂质积累和线粒体功能障碍的机制对肝细胞功能和活力产生不利影响.
- 黑色素显示出作为治疗剂的显著潜力,可以抵消微重力对肝细胞的有害影响.
- 对黑激素的保护机制的进一步研究可能会导致对太空飞行引起的肝脏疾病进行有效的干预.
相关概念视频
01:19Management of Insomnia
281
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
281
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
202
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
202